Tags : PIONEER-HF

Novartis Reports Results of Entresto (sacubitril/valsartan) in PIONEER-HF 4-Week Extension

Shots: The PIONEER-HF 4-week extension study involves assessing Entresto vs Enalapril in ~832 patients with systolic heart failure treated with Entresto for the first 8 wks.& the last 4wks and with enalapril and then switched to Entresto for the last 4wks. The PIONEER-HF 4-week extension study results: change in NT-proBNP (-18.5% vs -35.8%); symptomatic hypotension […]Read More